Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-12

Clinical Trial Update: A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis [Phase 4]

View source ↗

Summary

A Phase 4 trial compared risperidone long-acting injection with an oral antipsychotic in early psychosis; results were posted in 2013 and involve schizophrenia,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperidone Long Acting Injection (risperidone long-acting injectable)

Snippet

Sponsor: Janssen-Ortho Inc., Canada | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2013-11-12